Hans Van Vlierberghe

10PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - lipidsHaematological tumoursMedical biochemistry - proteins and peptides (incl. medical proteomics)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Richard S Finn, Masatoshi Kudo, Ivan Borbath

|May 23, 2025
The double-edged sword of metabolic and bariatric surgery: extending the biliary limb can trigger bacterial translocation, sepsis, and liver inflammation - an experimental study.

Louis Onghena, Anneleen Heldens, Kim De Paepe

|Aug 07, 2023
Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody.

Roos Van Den Noortgate, Maja Kiselinova, Céline Sys

|Aug 03, 2023
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.

Kevin De Muynck, Lander Heyerick, Federico F De Ponti

|Jan 28, 2023
Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease.

Louise Magherman, Robbe Van Parys, Nele S Pauwels

|Apr 14, 2022
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.

Gontran Verset, Ivan Borbath, Mark Karwal

Pageof 2

Frequent Collaborators

5 joint publications

Lindsey Devisscher

4 joint publications

Sander Lefere

3 joint publications

Anja Geerts

3 joint publications

Xavier Verhelst